Royalty Report: Skin care, Drugs, Medical – Collection: 324670

License Grant

Israeli Licensor hereby grants to Licensee a worldwide, perpetual, irrevocable exclusive license (with the right to grant sublicenses through multiple tiers) under the Licensor IP Rights to make, have made, use, offer for sale, sell and import the Product. For avoidance of doubt, the exclusive license is strictly limited to the Product and does not cover rights to the Licensor IP Rights for any product other than the Product. The foregoing license shall survive the termination or expiration of the term of the Agreement for any reason.

Licensor shall promptly disclose to Licensee all Product Technology. Licensee shall solely own all right, title and interest in and to the Product Technology and all patent and other intellectual property rights therein. Licensor hereby assigns to Licensee all of its right, title and interest in and to the Product Technology and all patent and other intellectual property rights therein.

License Property

Product means either a wash or cleanser containing a asteroid for topical application or a foam version of Licensees VanosTM product, as described in the Development Plan to be prepared by the parties.

Patent US2006/0057075

Field of Use

The field of use is for the treatment of skin conditions.

Skin conditions can include but not limited to facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis (improvement in the texture and appearance of skin).

License Grant

Licensor grants to Licensee and Affiliates of Licensee under the Licensed Patent Rights a non-exclusive license to make, have made, use, sell, and distribute in the Territory Licensed Products except through the Excluded Channel of Trade.

License Property

Licensed Products shall include any cosmetic and/or dermatologic preparation covered by the Licensed Patent Rights (a) containing glycolic acid and/or its salts (1) for the treatment of human skin wrinkles and/or fine lines on the human skin; (2) the treatment of dry skin; (3) as a skin cleanser; (4) as a hair conditioner; (5) as a shampoo; or (b) cosmetic and dermatologic preparations containing glycolic acid and/or its salts, in combination with salicylic acid for the treatment of acne; or (c) cosmetic and dermatologic preparations containing glycolic acid and/or its salts in combination with two percent (2%) or less of hydroquinone for the treatment of pigmented spots on human skin.

Licensed Patent Rights shall mean, those portions of the patents and patent applications, and all divisions, continuations, continuations-in-part, reissues, reexaminations and extensions thereof; (a) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts for (1) the treatment of human skin wrinkles and/or fine lines on the human skin; (2) the treatment of dry skin; (3) as a skin cleanser; (4) as a hair conditioner; (5) as a shampoo; (b) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts, in combination with salicylic acid for the treatment of acne; and (c) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts in combination with two percent (2%) or less of hydroquinone for the treatment of pigmented spots on human skin.

Excluded Channel of Trade shall mean the mail order, multi-level and direct door-to-door markets. Notwithstanding the Excluded Channel of Trade herein, Licensee may process orders made by customers of Licensee as a result of 800 telephone, toll-free telephone or telephone orders, provided that Licensee and its Affiliates shall not employ television, including without limitation, television infomercials, to advertise any 800 telephone, toll-free telephone or any telephone numbers to take, process or receive sales orders.

Field of Use

Patent rights were for products containing glycolic acids and its salts for the treatment of wrinkles and fine lines, dry skin, in combination with salicylic acid for the treatment of acne and in combination with hydroquinone 2% or less for the treatment of skin pigmentation, and as a skin cleanser, hair conditioner and shampoo.

License Grant

Licensor hereby grants to Licensee a perpetual, exclusive, non-transferable, irrevocable license (except in event of default by Licensee, or termination or expiration of this Agreement) to market, manufacture, sell, and distribute the Product to end users in the Territory. Notwithstanding, the foregoing, Licensee shall not sell the Product outside its Territory. Licensee has the right to “white-label” the Product with Licensee copyrights, trade names and/or trademarks.

Licensee shall have the exclusive right to use the IP (including US Patent number 10,111,821) solely in connection with Licensees manufacture, marketing, advertising, promotion and distribution of the Product. Licensees use of IP shall not create any right, title or interest therein. Licensee shall not adopt, use, or register, whether as a corporate name, trademark, service mark or other indication of origin, any IP, or any word or mark confusingly similar to those contained in the IP in any jurisdiction. Licensee hereby covenants and agrees that; (i) its use of IP will not dilute the IP; and (ii) the IP will be used in accordance with Licensor’s specifications. Licensee shall have right to use the Licensee intellectual property in the marketing of the Products.

License Property

Product shall mean Photocil Product that includes
* Technology transfer
* Transfer of manufacturing process
* Stability protocol
* Exclusive license to the US patent number 10,111,821 for the territory
* Access to existing marketing materials
* Access to existing packaging designs
* FDA listings
* Training on site
* Education and lectures in medical congresses if needed

U.S. Patent #10,111,821 – Methods and compositions for administering a specific wavelength phototherapy

Science
Health
Accesswire
Psoriasis
PRESS RELEASE Paid content from Accesswire
Jupiter Wellness Licenses Photocil(TM), a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis and Atopic Dermatitis
July 9, 2021
*Photo-Therapy in a tubJUPITER, FL / ACCESSWIRE / July 9, 2021 / Jupiter Wellness, Inc. (NASDAQJUPW), today announced they have entered into an exclusive agreement to license Photocilâ„¢, a novel patented topical cream that provides clinically-proven …
*Photo-Therapy in a tubJUPITER, FL / ACCESSWIRE / July 9, 2021 / Jupiter Wellness, Inc. (NASDAQJUPW), today announced they have entered into an exclusive agreement to license Photocilâ„¢, a novel patented topical cream that provides clinically-proven …
*Photo-Therapy in a tub

JUPITER, FL / ACCESSWIRE / July 9, 2021 / Jupiter Wellness, Inc.(NASDAQJUPW), today announced they have entered into an exclusive agreement to license Photocilâ„¢, a novel patented topical cream that provides clinically-proven relief for Psoriasis, Vitiligo and Atopic Dermatitis.

The Agrement signed with the Applied Biology (“AB”) whereby Jupiter Wellness is the exclusive licensee for Photocil in the United States. Under the terms of the Agreement, Jupiter Wellness has use of the copyrights, patents, technology, know-how, trademarks and trade-secrets of AB related to the use of Photocil. Jupiter Wellness has the exclusive right to use the IP (including US Patent number 10,111,821) solely in connection with the manufacture, marketing, advertising, promotion and distribution of Photocil™ for the treatment of skin conditions including Psoriasis and Vitiligo.

ADVERTISEMENT

Photocilâ„¢ is already sold in Europe, Asia and the Middle East as Presiluxâ„¢ and MediSun. The licensing of Photocilâ„¢ extends and complements the Jupiter Wellness strategy for the treatment of skin diseases such as Eczema, Psoriasis and Vitiligo. Jupiter Wellness previously reported that in a double-blinded, placebo controlled clinical trial, JW-100, its novel topical formulation containing CBD and Aspartame, was shown to significantly reduce the ISGA score in 50% of atopic dermatitis patients after two weeks of use.

Photocil cream acts as a barrier to non-therapeutic radiation from the sun when skin is exposed to direct daylight. With this barrier, Photocil cream allows you to access daytime self-treatment from the sun’s therapeutic (beneficial) UV radiation, otherwise known as phototherapy, in a safe and effective manner. With treatment sessions in direct daylight, Photocil delivers the same benefits of traditional phototherapy with a photo lamp, with more convenient access. Prior to the advent of Photocil cream, phototherapy was only available through a UV photo lamp, most commonly administered at a medical clinic.

Field of Use

Field of use for treatment of psoriasis, vitiligo, atopic dermatitis, eczema, acne, pruritus, and other therapeutic or cosmetic purposes.

Photocil is a novel patented topical cream that provides clinically-proven relief for Psoriasis, Vitiligo and Atopic Dermatitis.

License Grant

For good and valuable consideration, the adequacy of which is hereby acknowledged, the parties, intending to be legally bound, hereby agree to amend certain sections of the original agreement.  Royalty payments in consideration for the license granted has been amended.

License Property

The amended sections include but not limited to

Channel of Trade with respect to products containing glycolic acid shall mean the mail order, multi level, and direct door-to-door markets and to products containing gluconolactone shall mean any market or channel of distribution.

Licensed Products shall include any cosmetic and/or dermatologic preparation covered by the Licensed Patent Rights (a) containing glycolic acid and/or its salts (1) for the treatment of human skin wrinkles and/or fine lines on the human skin; (2) the treatment of dry skin; (3) as a skin cleanser; (4) as a hair conditioner; (5) as a shampoo; or (b) cosmetic and dermatologic preparations containing glycolic acid and/or its salts, in combination with salicylic acid for the treatment of acne; or (c) cosmetic and dermatologic preparations containing glycolic acid and/or its salts in combination with two percent (2%) or less of hydroquinone for the treatment of pigmented spots on human skin; or (d) cosmetic and dermatological preparations containing gluconolactone for alleviating or improving the signs of dermatological aging of the human skin, including the reduction of human skin wrinkles.

Licensed Patent Rights shall mean, subject to the specific exclusions set forth  (as amended herein), and all divisions, continuations, continuations-in-part, reissues, reexaminations and extensions thereof (a) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts for (1) the treatment of human skin wrinkles and/or fine lines on the human skin; (2) the treatment of dry skin; (3) as a skin cleanser; (4) as a hair conditioner; (5) as a shampoo; (b) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts, in combination with salicylic acid for the treatment of acne; (c) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts in combination with two percent (2%) or less of hydroquinone for the treatment of pigmented spots on human skin; and (d) covering only cosmetic and dermatological preparations containing gluconolactone for alleviating or improving the signs of dermatological aging of the human skin, including the reduction of human skin wrinkles.

Field of Use

This agreement pertains to skin care.